Biblio Discovery — Demo Discovery Service

9 results for "Kevin Budding"

Showing 1–9 · 1.08 seconds · RSS

  1. Journal Article

    Extracellular domain 1 of human FcγRI (CD64) identified as the binding site for anti-FcγRI antibodies

    Tosca Holtrop; Elsemieke M. Passchier; Sophie O’Toole et al.

    mAbs, Vol. 17 No. 1 · 2025 · English · DOAJ Scopus

    FcγRI (CD64) is the only Fcγ receptor capable of high-affinity binding to monomeric IgG and found on monocytes, macrophages, eosinophils, neutrophils, and dendritic cells. FcγRI contains three C2-type immunoglobulin (Ig) extracellular domains (EC1-3), while all other Fcγ receptors contain only two…

  2. Journal Article

    A Single Nucleotide C3 Polymorphism Associates With Clinical Outcome After Lung Transplantation

    Tineke Kardol-Hoefnagel; Kevin Budding; Eduard A. van de Graaf et al.

    Frontiers in Immunology, Vol. 10 · 2019 · English · DOAJ Scopus

    Background: Development of chronic rejection is still a severe problem and causes high mortality rates after lung transplantation (LTx). Complement activation is important in the development of acute rejection (AR) and bronchiolitis obliterans syndrome, with C3 as a key complement factor.Methods…

  3. Journal Article

    Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes following Lung Transplantation

    Laura A. Michielsen; Kevin Budding; Daniël Drop et al.

    Frontiers in Immunology, Vol. 8 · 2018 · English · DOAJ Scopus

    Cellular protection against undesired effects of complement activation is provided by expression of membrane-bound complement regulatory proteins including CD59. This protein prevents membrane attack complex formation and is considered to be involved in graft accommodation. Also, CD59 downregulates…

  4. Journal Article

    Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma

    Stefan Nierkens; Niels Eijkelkamp; Maaike Nederend et al.

    Journal for ImmunoTherapy of Cancer, Vol. 9 No. 10 · 2021 · English · DOAJ Scopus

    Background The addition of monoclonal antibody therapy against GD2 to the treatment of high-risk neuroblastoma led to improved responses in patients. Nevertheless, administration of GD2 antibodies against neuroblastoma is associated with therapy-limiting neuropathic pain. This severe pain is evoked…

  5. Journal Article Full text

    Tumor Acidosis Boosts Antibody-Driven Cytotoxic Potential of Neutrophils

    Tosca Holtrop; Ida C. van der Peet; Ilona S. T. Hendriks et al.

    Cells, Vol. 15 No. 18 · 2026 · English · DOAJ Scopus

    The acidic tumor microenvironment (pH 6.3–7.1) influences immune cell function, yet its impact on antibody-mediated killing remains poorly understood. While natural killer (NK) cells lose their spontaneous tumor-killing ability in acidic conditions, the effect on IgG-mediated killing is unexplored…

  6. Journal Article

    Association between a Single Donor TARC/CCL17 Promotor Polymorphism and Obstructive Chronic Lung Allograft Dysfunction after Lung Transplantation

    Kevin Budding; Jessica van Setten; Eduard A. van de Graaf et al.

    Frontiers in Immunology, Vol. 8 · 2017 · English · DOAJ Scopus

    Lung transplantation (LTx) outcome is hampered by development of chronic rejection, often manifested as the bronchiolitis obliterans syndrome (BOS). Low serum levels of thymus and activation-regulated chemokine (TARC/CCL17), a chemoattractant, measured during the first month post-LTx are predictive…

  7. Journal Article

    The Autoimmune-Associated Single Nucleotide Polymorphism Within PTPN22 Correlates With Clinical Outcome After Lung Transplantation

    Kevin Budding; Jessica van Setten; Eduard A. van de Graaf et al.

    Frontiers in Immunology, Vol. 9 · 2019 · English · DOAJ Scopus

    Obstructive chronic lung allograft dysfunction (BOS) is the major limiting factor for lung transplantation (LTx) outcome. PTPN22 is described as the hallmark autoimmunity gene, and one specific single nucleotide polymorphism (SNP), rs2476601, is associated with multiple autoimmune diseases…

  8. Journal Article

    IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onset

    Kevin Budding; Jeroen W. Bos; Kim Dijkxhoorn et al.

    Journal of Neuroinflammation, Vol. 21 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Background Multifocal motor neuropathy (MMN) is a rare, chronic immune-mediated polyneuropathy characterized by asymmetric distal limb weakness. An important feature of MMN is the presence of IgM antibodies against gangliosides, in particular GM1 and less often GM2. Antibodies against GM1…

  9. Journal Article

    Preclinical assessment of two FcγRI-specific antibodies that competitively inhibit immune complex-FcγRI binding to suppress autoimmune responses

    Tosca Holtrop; Arianne M. Brandsma; Louris J. Feitsma et al.

    Nature Communications, Vol. 16 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Overactivation of FcγRI by immune complexes (IC) is implicated in various autoimmune disorders and neuropathies. Currently, no effective FcγRI-specific blocking antibodies are available. Here we report preclinical data revealing two anti-FcγRI antibodies, C01 and C04, with high affinity…